diagnostics

News

AZ's Truqap and Roche assay cleared for PTEN prostate cancer

AstraZeneca has claimed a second approval for AKT inhibitor Truqap, in prostate cancer, that should help achieve its blockbuster hopes for the drug.

News

Roche develops Bundibugyo Ebola test in six days

A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of the current outbreak.

News

Roche buys AI-powered diagnostics player PathAI

Roche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy it for $1.05bn.

News

Blood test samples held by lab technician

Diagnostics lag is holding back new therapies, says study

Advances in therapeutics are outpacing the development of diagnostics due to policy and payment barriers, holding back effective, targeted care.

News

Elderly man talks to younger female nurse beside a Grail screening vehicle

Grail's multi-cancer test fluffs its lines in UK trial

Grail's Galleri blood test for cancer screening missed the mark in the much-anticipated NHS-Galleri trial, wreaking havoc with the firm's share price.

News

Grail multi-cancer test taps into Hims & Hers network

Grail has teamed up with telehealth company Hims & Hers to boost access to its recently filed Galleri blood test for cancer screening.

AZ's Truqap and Roche assay cleared for PTEN prostate cancer

Roche develops Bundibugyo Ebola test in six days

Roche buys AI-powered diagnostics player PathAI

Diagnostics lag is holding back new therapies, says study

Grail's multi-cancer test fluffs its lines in UK trial

Grail multi-cancer test taps into Hims & Hers network

ASCO 2026: Can a blood test spot cancer early? with Dr Peter...

Discover a new era of healthcare panel engagement: Grounded ...

diagnostics

Editor's Picks